HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...
Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...
News Medical on MSN
AI-powered wearable ECG system detects myocardial ischemia minutes earlier
Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...
(RTTNews) - HeartBeam, Inc. (BEAT), a medical technology company, announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company's groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results